German Chancellor Merz:
We had BioNTech, an extraordinarily successful company that became really big through coronavirus research and vaccine development.
This is a company that was developed in Germany with German support and has been extremely successful.
But when this company went to the capital markets, it didn't go to Frankfurt, Amsterdam, Paris or Madrid.
It went to New York, to Nasdaq.
And that's something I no longer want to see in the future.